Sofia Michael J.
- SEC CIK
- 0001635324
No open-market purchases or sales filed in the past year.
Current role at each company
- ABUS Arbutus Biopharma CorpChief Scientific Officeras of Feb 5, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Sofia Michael J. as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Feb 5, 2024 (view filing) | Feb 2 | 3 days | Sofia Michael J.Chief Scientific Officer | SSale | −9.98K | $2.31 | −$23.1K | −0.7%1.49M after | 10b5-1 |
| Dec 3, 2021 (view filing) | Dec 1 | 2 days | Sofia Michael J.Chief Scientific Officer | SSale | −200.0K | $5.09 | −$1.02M | −13.3%1.30M after |